Hope Is Not A Strategy: Drug Prices Impact On Medicare & Taxpayers

LinkedIn Ad

Introduction Lately, my LinkedIn feed has been persistently featuring this Alzheimer’s Association post. It calls for everyone to protest the draft decision by CMS (Centers for Medicare & Medicaid Services) to limit coverage for the Alzheimer’s drug, Aduhelm, hoping for an ultimate reversal. Nearly all of us, me included, have loved ones with Alzheimer’s. Even […]